Experts Want Labels For Pfizer, Moderna COVID-19 Vaccines Updated To Acknowledge Limitations

A coalition of experts is calling for U.S. officials to update the labels for the Pfizer and Moderna COVID-19 vaccines to acknowledge limitations to clinical trials, including stating clearly that the phase III trials that led to clearance did not provide evidence of efficacy against death. … Read More >Experts Want Labels For Pfizer, Moderna COVID-19 Vaccines Updated To Acknowledge Limitations

Moderna says its Covid vaccine is ‘well tolerated’ in 6- to 11-year-olds after fears of heart inflammation in young adults

Moderna Inc has claimed that its mRNA Covid vaccine is “well tolerated” in children between the ages of six to 11, and announced that the firm plans to submit the data from its study to regulatory bodies worldwide shortly. … Read More >Moderna says its Covid vaccine is ‘well tolerated’ in 6- to 11-year-olds after fears of heart inflammation in young adults

Sweden halts use of Moderna’s Covid vaccine for younger adults amid concerns over rare heart inflammation side effect

The Swedish Public Health Agency has decided to suspend offering Moderna’s Covid vaccine to anyone born in 1991 and later for precautionary reasons, citing the slightly increased risk of heart inflammation following inoculation. … Read More >Sweden halts use of Moderna’s Covid vaccine for younger adults amid concerns over rare heart inflammation side effect

South Korea to start Covid-19 vaccination of pregnant women as part of push to inoculate 80% of adults by end of October

South Korea will open vaccination against Covid-19 for pregnant women this month as part of the national campaign to vaccinate 80% of its adult population by the end of October. … Read More >South Korea to start Covid-19 vaccination of pregnant women as part of push to inoculate 80% of adults by end of October